Ticker | Entry | 2019 | 2018 |
---|---|---|---|
ALC | surgical::disclosure of operating segments::segment contribution, increase (decrease) | 34.00M | 33.00M |
ALC | vision care::disclosure of operating segments::segment contribution, increase (decrease) | 17.00M | 6.00M |
Ticker | Entry | 2024 | 2023 | 2022 |
---|---|---|---|---|
ALC | net sales | 9.84B | 9.37B | 8.65B |
ALC | operating income | 1.41B | 1.04B | 0.67B |
ALC | interest expense | -0.19B | -0.19B | -0.13B |
ALC | cost of net sales | -4.33B | -4.14B | -3.91B |
ALC | cost of other revenues | -0.07B | -0.07B | -0.06B |
ALC | income before tax | 1.26B | 0.83B | 0.46B |
ALC | other expense | -0.05B | -0.25B | -0.34B |
ALC | other financial income & expense | 0.04B | -0.02B | -0.07B |
ALC | other income | 0.08B | 0.08B | 0.04B |
ALC | other revenues | 0.07B | 0.09B | 0.06B |
ALC | research & development | -0.88B | -0.83B | -0.70B |
ALC | selling, general & administration | -3.25B | -3.21B | -3.07B |
ALC | share of (loss) from associated companies | -0.01B | 0.0 | 0.0 |
ALC | total depreciation of property, plant & equipment | -0.39B | -0.39B | -0.33B |
ALC | total depreciation of right-of-use assets | -0.08B | -0.09B | -0.08B |
ALC | total equity-based compensation | -0.16B | -0.16B | -0.15B |
ALC | total impairment charges on property, plant & equipment, net | -0.00B | 0.0 | -0.00B |
ALC | not allocated to segments::cost of net sales | -0.71B | -0.71B | -0.67B |
ALC | not allocated to segments::interest expense | -0.19B | -0.19B | -0.13B |
ALC | not allocated to segments::operating income | -1.02B | -1.19B | -1.26B |
ALC | not allocated to segments::other expense | -0.05B | -0.25B | -0.34B |
ALC | not allocated to segments::other financial income & expense | 0.04B | -0.02B | -0.07B |
ALC | not allocated to segments::other income | 0.08B | 0.08B | 0.04B |
ALC | not allocated to segments::research & development | -0.01B | -0.01B | -0.00B |
ALC | not allocated to segments::selling, general & administration | -0.32B | -0.30B | -0.29B |
ALC | not allocated to segments::total depreciation of property, plant & equipment | -0.00B | -0.00B | -0.00B |
ALC | not allocated to segments::total equity-based compensation | -0.02B | -0.02B | -0.02B |
ALC | operating segments::net sales | 9.84B | 9.37B | 8.65B |
ALC | operating segments::other revenues | 0.0 | 0.09B | 0.06B |
ALC | surgical::cost of net sales | -2.01B | -1.90B | -1.83B |
ALC | surgical::cost of other revenues | -0.00B | 0.0 | 0.0 |
ALC | surgical::net sales | 5.52B | 5.31B | 5.04B |
ALC | surgical::operating income | 1.47B | 1.45B | 1.34B |
ALC | surgical::other revenues | 0.00B | 0.0 | 0.0 |
ALC | surgical::research & development | -0.58B | -0.53B | -0.49B |
ALC | surgical::selling, general & administration | -1.46B | -1.44B | -1.39B |
ALC | surgical::total depreciation of property, plant & equipment | -0.15B | -0.14B | -0.13B |
ALC | surgical::total depreciation of right-of-use assets | -0.05B | -0.05B | -0.05B |
ALC | surgical::total equity-based compensation | -0.08B | -0.08B | -0.07B |
ALC | vision care::cost of net sales | -1.60B | -1.53B | -1.41B |
ALC | vision care::cost of other revenues | -0.07B | -0.07B | -0.06B |
ALC | vision care::net sales | 4.31B | 4.06B | 3.61B |
ALC | vision care::operating income | 0.96B | 0.78B | 0.60B |
ALC | vision care::other revenues | 0.07B | 0.09B | 0.06B |
ALC | vision care::research & development | -0.28B | -0.29B | -0.21B |
ALC | vision care::selling, general & administration | -1.47B | -1.47B | -1.39B |
ALC | vision care::total depreciation of property, plant & equipment | -0.24B | -0.24B | -0.20B |
ALC | vision care::total depreciation of right-of-use assets | -0.03B | -0.04B | -0.03B |
ALC | vision care::total equity-based compensation | -0.06B | -0.06B | -0.06B |
Ticker | Entry | 2023 | 2022 | 2021 | 2020 | 2019 |
---|---|---|---|---|---|---|
ALC | operating income | 1.04B | 0.67B | 0.58B | -0.48B | -0.19B |
ALC | interest expense | -0.19B | -0.13B | -0.12B | -0.12B | -0.11B |
ALC | acquisition and integration related costs | -0.05B | -0.06B | 0.0 | 0.0 | 0.0 |
ALC | amortization of intangible assets | -0.74B | -0.65B | -0.59B | -1.08B | -1.08B |
ALC | fair value adjustments to contingent consideration liabilities | 0.02B | 0.02B | 0.04B | 0.06B | 0.07B |
ALC | general & administration (corporate) | -0.27B | -0.26B | -0.25B | -0.23B | -0.22B |
ALC | impairment charges | 0.0 | -0.06B | -0.23B | -0.17B | 0.0 |
ALC | impairment charges on intangible assets | 0.0 | -0.06B | -0.23B | 0.0 | 0.0 |
ALC | income before tax | 0.83B | 0.46B | 0.42B | -0.64B | -0.33B |
ALC | other | -0.06B | -0.13B | -0.10B | -0.05B | -0.14B |
ALC | other financial income & expense | -0.02B | -0.07B | -0.04B | -0.03B | -0.03B |
ALC | past service costs and settlements | 0.0 | 0.0 | 0.02B | 0.15B | -0.00B |
ALC | past service costs for post-employment benefit plan amendments | 0.0 | 0.0 | 0.02B | 0.0 | 0.0 |
ALC | release of contingent liability related to a recent acquisition | 0.06B | 0.0 | 0.0 | 0.0 | 0.0 |
ALC | segment contribution | 0.0 | 1.94B | 1.79B | 1.09B | 1.54B |
ALC | separation costs | 0.0 | 0.0 | -0.04B | -0.22B | -0.24B |
ALC | total depreciation of property, plant & equipment | -0.39B | -0.33B | -0.32B | -0.29B | -0.27B |
ALC | total depreciation of right-of-use assets | -0.09B | -0.08B | -0.08B | -0.08B | -0.07B |
ALC | total equity-based compensation | -0.16B | -0.15B | -0.15B | -0.11B | -0.11B |
ALC | total impairment charges on property, plant & equipment, net | 0.0 | -0.00B | 0.0 | -0.01B | -0.01B |
ALC | total segment contribution | 2.23B | 1.94B | 1.79B | 0.0 | 0.0 |
ALC | transformation costs | -0.14B | -0.12B | -0.07B | -0.05B | -0.05B |
ALC | not allocated to segments::total depreciation of property, plant & equipment | -0.00B | -0.00B | 0.0 | 0.0 | 0.0 |
ALC | not allocated to segments::total equity-based compensation | -0.02B | -0.02B | -0.02B | -0.01B | -0.01B |
ALC | surgical::impairment charges | 0.0 | -0.06B | -0.18B | -0.07B | 0.0 |
ALC | surgical::impairment charges on intangible assets | 0.0 | -0.06B | 0.0 | 0.0 | 0.0 |
ALC | surgical::segment contribution | 0.0 | 1.34B | 1.18B | 0.67B | 0.96B |
ALC | surgical::total depreciation of property, plant & equipment | -0.14B | -0.13B | -0.13B | -0.12B | -0.11B |
ALC | surgical::total depreciation of right-of-use assets | -0.05B | -0.05B | -0.05B | -0.05B | -0.04B |
ALC | surgical::total equity-based compensation | -0.08B | -0.07B | -0.07B | -0.06B | -0.06B |
ALC | surgical::total impairment charges on property, plant & equipment, net | 0.0 | -0.00B | 0.0 | -0.01B | -0.00B |
ALC | surgical::total segment contribution | 1.45B | 1.34B | 1.18B | 0.0 | 0.0 |
ALC | vision care::impairment charges | 0.0 | -0.00B | -0.05B | -0.10B | 0.0 |
ALC | vision care::impairment charges on intangible assets | 0.0 | -0.00B | -0.05B | 0.0 | 0.0 |
ALC | vision care::segment contribution | 0.0 | 0.60B | 0.60B | 0.42B | 0.58B |
ALC | vision care::total depreciation of property, plant & equipment | -0.24B | -0.20B | -0.19B | -0.17B | -0.15B |
ALC | vision care::total depreciation of right-of-use assets | -0.04B | -0.03B | -0.03B | -0.03B | -0.02B |
ALC | vision care::total equity-based compensation | -0.06B | -0.06B | -0.06B | -0.04B | -0.04B |
ALC | vision care::total segment contribution | 0.78B | 0.60B | 0.60B | 0.0 | 0.0 |
Ticker | Entry | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
---|---|---|---|---|---|---|---|---|---|
ALC | net sales | 9.84B | 9.37B | 8.65B | 0.0 | 6.76B | 7.36B | 7.15B | 6.79B |
ALC | net sales and other revenues | 9.91B | 9.46B | 8.72B | 8.29B | 6.83B | 7.51B | 0.0 | 0.0 |
ALC | net sales to third parties | 0.0 | 9.37B | 8.65B | 8.22B | 6.76B | 7.36B | 0.0 | 0.0 |
ALC | other revenues | 0.0 | 0.09B | 0.06B | 0.07B | 0.07B | 0.15B | 0.0 | 0.0 |
ALC | total other revenues | 0.07B | 0.09B | 0.06B | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
ALC | operating segments::net sales | 9.84B | 9.37B | 8.65B | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
ALC | operating segments::total other revenues | 0.0 | 0.09B | 0.06B | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
ALC | surgical | consumables::net sales | 2.86B | 2.72B | 2.50B | 0.0 | 1.95B | 2.30B | 2.23B | 2.10B |
ALC | surgical | consumables::net sales to third parties | 0.0 | 2.72B | 2.50B | 2.39B | 1.95B | 2.30B | 0.0 | 0.0 |
ALC | surgical | equipment & other::net sales | 0.0 | 0.0 | 0.0 | 0.0 | 0.63B | 0.66B | 0.64B | 0.58B |
ALC | surgical | equipment/other::net sales | 0.89B | 0.89B | 0.82B | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
ALC | surgical | equipment/other::net sales to third parties | 0.0 | 0.89B | 0.82B | 0.79B | 0.63B | 0.66B | 0.0 | 0.0 |
ALC | surgical | implantables::net sales | 1.77B | 1.70B | 1.73B | 0.0 | 1.13B | 1.21B | 1.14B | 1.04B |
ALC | surgical | implantables::net sales to third parties | 0.0 | 1.70B | 1.73B | 1.52B | 1.13B | 1.21B | 0.0 | 0.0 |
ALC | surgical::net sales | 5.52B | 5.31B | 5.04B | 0.0 | 3.71B | 4.17B | 4.00B | 3.73B |
ALC | surgical::net sales to third parties | 0.0 | 5.31B | 5.04B | 4.70B | 3.71B | 4.17B | 0.0 | 0.0 |
ALC | vision care | contact lenses::net sales | 2.61B | 2.40B | 2.19B | 0.0 | 1.84B | 1.97B | 1.93B | 1.84B |
ALC | vision care | contact lenses::net sales to third parties | 0.0 | 2.40B | 2.19B | 2.14B | 1.84B | 1.97B | 0.0 | 0.0 |
ALC | vision care | ocular health::net sales | 1.71B | 1.66B | 1.42B | 0.0 | 1.22B | 1.22B | 1.22B | 1.22B |
ALC | vision care | ocular health::net sales to third parties | 0.0 | 1.66B | 1.42B | 1.38B | 1.22B | 1.22B | 0.0 | 0.0 |
ALC | vision care::net sales | 4.31B | 4.06B | 3.61B | 0.0 | 3.05B | 3.19B | 3.15B | 3.05B |
ALC | vision care::net sales to third parties | 0.0 | 4.06B | 3.61B | 3.52B | 3.05B | 3.19B | 0.0 | 0.0 |
ALC | vision care::total other revenues | 0.07B | 0.09B | 0.06B | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Ticker | Entry | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
---|---|---|---|---|---|---|---|---|
ALC | intangible assets and goodwill | 8.59B | 9.06B | 9.69B | 8.77B | 9.10B | 10.23B | 10.68B |
ALC | acquired in-process research & development::intangible assets and goodwill | 0.78B | 0.74B | 0.74B | 0.56B | 0.73B | 0.72B | 0.25B |
ALC | alcon brand name::intangible assets and goodwill | 2.98B | 2.98B | 2.98B | 2.98B | 2.98B | 2.98B | 2.98B |
ALC | currently marketed products::intangible assets and goodwill | 1.74B | 2.02B | 2.38B | 1.33B | 1.24B | 1.60B | 1.85B |
ALC | goodwill::intangible assets and goodwill | 8.95B | 8.93B | 8.97B | 8.90B | 8.90B | 8.90B | 8.90B |
ALC | marketing know-how::intangible assets and goodwill | 2.62B | 2.86B | 3.10B | 3.34B | 3.58B | 3.81B | 4.05B |
ALC | not allocated to segments | alcon brand name::intangible assets and goodwill | 2.98B | 2.98B | 2.98B | 2.98B | 2.98B | 2.98B | 2.98B |
ALC | not allocated to segments::intangible assets and goodwill | 2.98B | 2.98B | 2.98B | 2.98B | 2.98B | 2.98B | 2.98B |
ALC | other (including software)::intangible assets and goodwill | 0.44B | 0.40B | 0.40B | 0.43B | 0.40B | 0.44B | 0.37B |
ALC | surgical | acquired in-process research & development::intangible assets and goodwill | 0.56B | 0.56B | 0.56B | 0.56B | 0.72B | 0.72B | 0.22B |
ALC | surgical | currently marketed products::intangible assets and goodwill | 0.58B | 0.53B | 0.58B | 0.23B | 0.25B | 0.37B | 0.44B |
ALC | surgical | goodwill::intangible assets and goodwill | 4.56B | 4.54B | 4.54B | 4.54B | 4.54B | 4.54B | 4.54B |
ALC | surgical | marketing know-how::intangible assets and goodwill | 2.62B | 2.86B | 3.10B | 3.34B | 3.58B | 0.0 | 0.0 |
ALC | surgical | other (including software)::intangible assets and goodwill | 0.27B | 0.24B | 0.24B | 0.25B | 0.24B | 0.18B | 0.16B |
ALC | surgical | technologies::intangible assets and goodwill | 0.03B | 0.06B | 0.09B | 0.13B | 0.17B | 0.0 | 0.0 |
ALC | surgical::intangible assets and goodwill | 4.06B | 4.26B | 4.58B | 4.50B | 4.95B | 5.77B | 6.05B |
ALC | technologies::intangible assets and goodwill | 0.03B | 0.06B | 0.09B | 0.13B | 0.17B | 0.68B | 1.19B |
ALC | vision care | acquired in-process research & development::intangible assets and goodwill | 0.21B | 0.17B | 0.17B | 0.00B | 0.00B | 0.00B | 0.03B |
ALC | vision care | currently marketed products::intangible assets and goodwill | 1.16B | 1.48B | 1.80B | 1.10B | 1.00B | 1.22B | 1.41B |
ALC | vision care | goodwill::intangible assets and goodwill | 4.38B | 4.38B | 4.43B | 4.36B | 4.36B | 4.36B | 4.36B |
ALC | vision care | other (including software)::intangible assets and goodwill | 0.17B | 0.16B | 0.16B | 0.18B | 0.16B | 0.25B | 0.21B |
ALC | vision care::intangible assets and goodwill | 1.54B | 1.82B | 2.13B | 1.28B | 1.16B | 1.48B | 1.65B |
Ticker | Entry | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
---|---|---|---|---|---|---|---|---|---|
ALC | net sales | 9.84B | 9.37B | 8.65B | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
ALC | intangible assets and goodwill | 0.0 | 9.06B | 9.69B | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
ALC | net sales to third parties | 0.0 | 9.37B | 8.65B | 8.22B | 6.76B | 7.36B | 7.15B | 6.79B |
ALC | percentage of entity's non-current asset | 0.0 | 0.0 | 100.00% | 100.00% | 0.0 | 0.0 | 0.0 | 0.0 |
ALC | percentage of entity's non-current asset (as a percent) | 0.0 | 100.00% | 100.00% | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
ALC | percentage of entity's revenue | 0.0 | 0.0 | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% |
ALC | percentage of entity's revenue (as a percent) | 100.00% | 100.00% | 100.00% | 100.00% | 0.0 | 0.0 | 0.0 | 0.0 |
ALC | total of selected non-current asset | 0.0 | 22.71B | 23.07B | 21.75B | 21.79B | 22.57B | 22.46B | 0.0 |
ALC | percentage of entity's non-current assets (as a percent) | 100.00% | 100.00% | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
ALC | total of selected non-current assets | 22.37B | 22.71B | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
ALC | china::net sales | 0.56B | 0.53B | 0.47B | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
ALC | china::percentage of entity's revenue (as a percent) | 6.00% | 6.00% | 5.00% | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
ALC | china::total of selected non-current assets | 0.02B | 0.01B | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
ALC | country of domicile | switzerland::net sales to third parties | 0.0 | 64000000.00 | 59000000.00 | 60000000.00 | 55000000.00 | 56000000.00 | 57000000.00 | 57000000.00 |
ALC | country of domicile | switzerland::percentage of entity's non-current asset | 0.0 | 0.0 | 41000000.00 | 45.00 | 45.00 | 46.00 | 50.00 | 0.0 |
ALC | country of domicile | switzerland::percentage of entity's non-current asset (as a percent) | 0.0 | 40000000.00 | 41000000.00 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
ALC | country of domicile | switzerland::percentage of entity's revenue | 0.0 | 0.0 | 1000000.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
ALC | country of domicile | switzerland::percentage of entity's revenue (as a percent) | 0.0 | 1000000.00 | 1000000.00 | 1.00 | 0.0 | 0.0 | 0.0 | 0.0 |
ALC | country of domicile | switzerland::total of selected non-current asset | 0.0 | 9137000.00 | 9462000000.00 | 9762000000.00 | 9737000000.00 | 10486000000.00 | 11166000000.00 | 0.0 |
ALC | foreign countries | china::net sales to third parties | 0.0 | 526000000.00 | 474000000.00 | 486000000.00 | 383000000.00 | 377000000.00 | 341000000.00 | 279000000.00 |
ALC | foreign countries | china::percentage of entity's revenue | 0.0 | 0.0 | 5000000.00 | 6.00 | 6.00 | 5.00 | 5.00 | 4.00 |
ALC | foreign countries | china::percentage of entity's revenue (as a percent) | 0.0 | 6000000.00 | 5000000.00 | 6.00 | 0.0 | 0.0 | 0.0 | 0.0 |
ALC | foreign countries | china::total of selected non-current asset | 0.0 | 10000000.00 | 9000000.00 | 16000000.00 | 16000000.00 | 18000000.00 | 2000000.00 | 0.0 |
ALC | foreign countries | japan::net sales to third parties | 0.0 | 583000000.00 | 568000000.00 | 621000000.00 | 650000000.00 | 656000000.00 | 593000000.00 | 561000000.00 |
ALC | foreign countries | japan::percentage of entity's revenue | 0.0 | 0.0 | 7000000.00 | 8.00 | 10.00 | 9.00 | 8.00 | 8.00 |
ALC | foreign countries | japan::percentage of entity's revenue (as a percent) | 0.0 | 6000000.00 | 7000000.00 | 8.00 | 0.0 | 0.0 | 0.0 | 0.0 |
ALC | foreign countries | japan::total of selected non-current asset | 0.0 | 34000000.00 | 44000000.00 | 46000000.00 | 63000000.00 | 66000000.00 | 12000000.00 | 0.0 |
ALC | foreign countries | other::net sales to third parties | 0.0 | 3885000000.00 | 3656000000.00 | 3404000000.00 | 2700000000.00 | 3218000000.00 | 3216000000.00 | 3088000000.00 |
ALC | foreign countries | other::percentage of entity's non-current asset | 0.0 | 0.0 | 8000000.00 | 8.00 | 8.00 | 6.00 | 5.00 | 0.0 |
ALC | foreign countries | other::percentage of entity's non-current asset (as a percent) | 0.0 | 9000000.00 | 8000000.00 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
ALC | foreign countries | other::percentage of entity's revenue | 0.0 | 0.0 | 42000000.00 | 41.00 | 40.00 | 44.00 | 45.00 | 46.00 |
ALC | foreign countries | other::percentage of entity's revenue (as a percent) | 0.0 | 41000000.00 | 42000000.00 | 41.00 | 0.0 | 0.0 | 0.0 | 0.0 |
ALC | foreign countries | other::total of selected non-current asset | 0.0 | 2038000000.00 | 1821000000.00 | 1729000000.00 | 1660000000.00 | 1444000000.00 | 1221000000.00 | 0.0 |
ALC | foreign countries | united states::net sales to third parties | 0.0 | 4312000000.00 | 3897000000.00 | 3651000000.00 | 2975000000.00 | 3055000000.00 | 2942000000.00 | 2800000000.00 |
ALC | foreign countries | united states::percentage of entity's non-current asset | 0.0 | 0.0 | 51000000.00 | 47.00 | 47.00 | 47.00 | 45.00 | 0.0 |
ALC | foreign countries | united states::percentage of entity's non-current asset (as a percent) | 0.0 | 51000000.00 | 51000000.00 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
ALC | foreign countries | united states::percentage of entity's revenue | 0.0 | 0.0 | 45000000.00 | 44.00 | 44.00 | 41.00 | 41.00 | 41.00 |
ALC | foreign countries | united states::percentage of entity's revenue (as a percent) | 0.0 | 46000000.00 | 45000000.00 | 44.00 | 0.0 | 0.0 | 0.0 | 0.0 |
ALC | foreign countries | united states::total of selected non-current asset | 0.0 | 11490000.00 | 11739000.00 | 10200000000.00 | 10309000000.00 | 10559000000.00 | 10056000000.00 | 0.0 |
ALC | goodwill::intangible assets and goodwill | 0.0 | 8.93B | 8.93B | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
ALC | international::net sales | 5.33B | 5.06B | 4.76B | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
ALC | international::net sales to third parties | 0.0 | 5.06B | 4.76B | 4.57B | 3.79B | 4.31B | 4.21B | 3.98B |
ALC | international::percentage of entity's non-current asset | 0.0 | 0.0 | 49.00% | 53.00% | 53.00% | 53.00% | 55.00% | 0.0 |
ALC | international::percentage of entity's non-current asset (as a percent) | 0.0 | 49.00% | 49.00% | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
ALC | international::percentage of entity's non-current assets (as a percent) | 49.00% | 49.00% | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
ALC | international::percentage of entity's revenue | 0.0 | 0.0 | 55.00% | 56.00% | 56.00% | 59.00% | 59.00% | 59.00% |
ALC | international::percentage of entity's revenue (as a percent) | 54.00% | 54.00% | 55.00% | 56.00% | 0.0 | 0.0 | 0.0 | 0.0 |
ALC | international::total of selected non-current asset | 0.0 | 11.22B | 11.34B | 11.55B | 11.48B | 12.01B | 12.40B | 0.0 |
ALC | international::total of selected non-current assets | 10.99B | 11.22B | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
ALC | japan::net sales | 0.55B | 0.58B | 0.57B | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
ALC | japan::percentage of entity's revenue (as a percent) | 6.00% | 6.00% | 7.00% | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
ALC | japan::total of selected non-current assets | 0.03B | 0.03B | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
ALC | other::net sales | 4.13B | 3.88B | 3.66B | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
ALC | other::percentage of entity's non-current assets (as a percent) | 10.00% | 9.00% | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
ALC | other::percentage of entity's revenue (as a percent) | 42.00% | 41.00% | 42.00% | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
ALC | other::total of selected non-current assets | 2.14B | 2.04B | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
ALC | switzerland::net sales | 0.08B | 0.06B | 0.06B | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
ALC | switzerland::percentage of entity's non-current assets (as a percent) | 39.00% | 40.00% | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
ALC | switzerland::percentage of entity's revenue (as a percent) | 1.00% | 1.00% | 1.00% | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
ALC | switzerland::total of selected non-current assets | 8.80B | 9.14B | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
ALC | united states::net sales | 4.51B | 4.31B | 3.90B | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
ALC | united states::percentage of entity's non-current assets (as a percent) | 51.00% | 51.00% | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
ALC | united states::percentage of entity's revenue (as a percent) | 46.00% | 46.00% | 45.00% | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
ALC | united states::total of selected non-current assets | 11.38B | 11.49B | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Ticker | Entry | 2020 | 2019 | 2018 | 2017 |
---|---|---|---|---|---|
ALC | interest expense | -124.00M | -113.00M | -24.00M | -27.00M |
ALC | (loss) before tax | -635.00M | -332.00M | -300.00M | -127.00M |
ALC | amortization of intangible assets | -1078.00M | -1084.00M | -1019.00M | -1033.00M |
ALC | contingent consideration asset (liability), fair value adjustment | 63.00M | 75.00M | 62.00M | 0.0 |
ALC | depreciation of property, plant & equipment | -293.00M | -267.00M | -239.00M | -215.00M |
ALC | depreciation of right-of-use assets | -79.00M | -66.00M | 0.0 | 0.0 |
ALC | equity-based compensation | -113.00M | -114.00M | -93.00M | -71.00M |
ALC | general & administration (corporate) | -232.00M | -216.00M | -206.00M | -202.00M |
ALC | impairment charges on intangible assets | -167.00M | 0.0 | -378.00M | -57.00M |
ALC | impairment charges on property, plant & equipment, net | -6.00M | -8.00M | -2.00M | 0.0 |
ALC | net sales and other revenues | 6833.00M | 7508.00M | 7153.00M | 6792.00M |
ALC | net sales to third parties | 6763.00M | 7362.00M | 7149.00M | 6785.00M |
ALC | operating (loss) | -482.00M | -187.00M | -248.00M | -77.00M |
ALC | other | -47.00M | -136.00M | -52.00M | -101.00M |
ALC | other financial income & expense | -29.00M | -32.00M | -28.00M | -23.00M |
ALC | other revenues | 70.00M | 146.00M | 0.0 | 3.00M |
ALC | past service costs for post-employment benefit plan amendments | 154.00M | -2.00M | -1.00M | 0.0 |
ALC | payables contingent consideration | -63.00M | -75.00M | -62.00M | 0.0 |
ALC | sales to former parent | 0.0 | 0.0 | 4.00M | 4.00M |
ALC | segment contribution | 1091.00M | 1537.00M | 1446.00M | 1316.00M |
ALC | separation costs | -217.00M | -237.00M | 0.0 | 0.0 |
ALC | spin readiness costs | 0.0 | -72.00M | -32.00M | 0.0 |
ALC | transformation costs | -49.00M | -52.00M | 0.0 | 0.0 |
ALC | surgical::depreciation of property, plant & equipment | -122.00M | -112.00M | -114.00M | -106.00M |
ALC | surgical::depreciation of right-of-use assets | -47.00M | -42.00M | 0.0 | 0.0 |
ALC | surgical::equity-based compensation | -55.00M | -55.00M | -45.00M | -34.00M |
ALC | surgical::impairment charges on intangible assets | -66.00M | 0.0 | -378.00M | 0.0 |
ALC | surgical::impairment charges on property, plant & equipment, net | -6.00M | -3.00M | -1.00M | 0.0 |
ALC | surgical::net sales and other revenues | 3710.00M | 4174.00M | 4001.00M | 3736.00M |
ALC | surgical::net sales to third parties | 3710.00M | 4174.00M | 3999.00M | 3733.00M |
ALC | surgical::sales to former parent | 0.0 | 0.0 | 2.00M | 3.00M |
ALC | surgical::segment contribution | 672.00M | 957.00M | 846.00M | 691.00M |
ALC | unallocated amounts::equity-based compensation | -13.00M | -15.00M | -12.00M | -10.00M |
ALC | vision care::depreciation of property, plant & equipment | -171.00M | -155.00M | -125.00M | -109.00M |
ALC | vision care::depreciation of right-of-use assets | -32.00M | -24.00M | 0.0 | 0.0 |
ALC | vision care::equity-based compensation | -45.00M | -44.00M | -36.00M | -27.00M |
ALC | vision care::impairment charges on intangible assets | -101.00M | 0.0 | 0.0 | 0.0 |
ALC | vision care::impairment charges on property, plant & equipment, net | 0.0 | -5.00M | -1.00M | 0.0 |
ALC | vision care::net sales and other revenues | 3123.00M | 3334.00M | 3152.00M | 3056.00M |
ALC | vision care::net sales to third parties | 3053.00M | 3188.00M | 3150.00M | 3052.00M |
ALC | vision care::sales to former parent | 0.0 | 0.0 | 2.00M | 1.00M |
ALC | vision care::segment contribution | 419.00M | 580.00M | 600.00M | 625.00M |
Ticker | Entry | 2024 | 2023 | 2022 |
---|---|---|---|---|
ALC | net sales | 100.00% | 100.00% | 100.00% |
ALC | operating income | 14.37% | 11.09% | 7.77% |
ALC | interest expense | -1.95% | -2.02% | -1.55% |
ALC | cost of net sales | -44.00% | -44.19% | -45.18% |
ALC | cost of other revenues | -0.72% | -0.72% | -0.68% |
ALC | income before tax | 12.77% | 8.88% | 5.35% |
ALC | other expense | -0.51% | -2.68% | -3.95% |
ALC | other financial income & expense | 0.44% | -0.19% | -0.87% |
ALC | other income | 0.78% | 0.85% | 0.42% |
ALC | other revenues | 0.76% | 0.91% | 0.73% |
ALC | research & development | -8.91% | -8.84% | -8.11% |
ALC | selling, general & administration | -33.04% | -34.25% | -35.45% |
ALC | share of (loss) from associated companies | -0.08% | 0.0 | 0.0 |
ALC | total depreciation of property, plant & equipment | -3.99% | -4.11% | -3.81% |
ALC | total depreciation of right-of-use assets | -0.84% | -0.97% | -0.88% |
ALC | total equity-based compensation | -1.65% | -1.70% | -1.76% |
ALC | total impairment charges on property, plant & equipment, net | -0.01% | 0.0 | -0.02% |
ALC | not allocated to segments::cost of net sales | -7.21% | -7.56% | -7.68% |
ALC | not allocated to segments::interest expense | -1.95% | -2.02% | -1.55% |
ALC | not allocated to segments::operating income | -10.33% | -12.72% | -14.61% |
ALC | not allocated to segments::other expense | -0.51% | -2.68% | -3.95% |
ALC | not allocated to segments::other financial income & expense | 0.44% | -0.19% | -0.87% |
ALC | not allocated to segments::other income | 0.78% | 0.85% | 0.42% |
ALC | not allocated to segments::research & development | -0.12% | -0.13% | -0.05% |
ALC | not allocated to segments::selling, general & administration | -3.27% | -3.21% | -3.34% |
ALC | not allocated to segments::total depreciation of property, plant & equipment | -0.04% | -0.04% | -0.01% |
ALC | not allocated to segments::total equity-based compensation | -0.23% | -0.18% | -0.20% |
ALC | operating segments::net sales | 100.00% | 100.00% | 100.00% |
ALC | operating segments::other revenues | 0.0 | 0.91% | 0.73% |
ALC | surgical::cost of net sales | -20.48% | -20.26% | -21.20% |
ALC | surgical::cost of other revenues | -0.04% | 0.0 | 0.0 |
ALC | surgical::net sales | 56.14% | 56.71% | 58.30% |
ALC | surgical::operating income | 14.91% | 15.52% | 15.44% |
ALC | surgical::other revenues | 0.04% | 0.0 | 0.0 |
ALC | surgical::research & development | -5.90% | -5.62% | -5.62% |
ALC | surgical::selling, general & administration | -14.85% | -15.31% | -16.04% |
ALC | surgical::total depreciation of property, plant & equipment | -1.49% | -1.54% | -1.51% |
ALC | surgical::total depreciation of right-of-use assets | -0.51% | -0.52% | -0.53% |
ALC | surgical::total equity-based compensation | -0.82% | -0.83% | -0.86% |
ALC | vision care::cost of net sales | -16.32% | -16.38% | -16.29% |
ALC | vision care::cost of other revenues | -0.68% | -0.72% | -0.68% |
ALC | vision care::net sales | 43.86% | 43.29% | 41.70% |
ALC | vision care::operating income | 9.78% | 8.29% | 6.93% |
ALC | vision care::other revenues | 0.72% | 0.91% | 0.73% |
ALC | vision care::research & development | -2.89% | -3.08% | -2.45% |
ALC | vision care::selling, general & administration | -14.91% | -15.72% | -16.07% |
ALC | vision care::total depreciation of property, plant & equipment | -2.45% | -2.53% | -2.29% |
ALC | vision care::total depreciation of right-of-use assets | -0.34% | -0.45% | -0.35% |
ALC | vision care::total equity-based compensation | -0.59% | -0.68% | -0.70% |
Ticker | Entry | 2023 | 2022 | 2021 |
---|---|---|---|---|
ALC | operating income | 46.57% | 34.71% | 32.44% |
ALC | interest expense | -8.47% | -6.92% | -6.71% |
ALC | acquisition and integration related costs | -2.15% | -3.31% | 0.0 |
ALC | amortization of intangible assets | -33.39% | -33.73% | -33.00% |
ALC | fair value adjustments to contingent consideration liabilities | 0.76% | 1.19% | 2.35% |
ALC | general & administration (corporate) | -12.19% | -13.17% | -14.04% |
ALC | impairment charges | 0.0 | -3.20% | -12.58% |
ALC | impairment charges on intangible assets | 0.0 | -3.20% | -12.58% |
ALC | income before tax | 37.29% | 23.92% | 23.38% |
ALC | other | -2.82% | -6.92% | -5.48% |
ALC | other financial income & expense | -0.81% | -3.87% | -2.35% |
ALC | past service costs and settlements | 0.0 | 0.0 | 1.01% |
ALC | past service costs for post-employment benefit plan amendments | 0.0 | 0.0 | 1.01% |
ALC | release of contingent liability related to a recent acquisition | 2.60% | 0.0 | 0.0 |
ALC | segment contribution | 0.0 | 100.00% | 100.00% |
ALC | separation costs | 0.0 | 0.0 | -2.01% |
ALC | total depreciation of property, plant & equipment | -17.26% | -17.05% | -18.06% |
ALC | total depreciation of right-of-use assets | -4.08% | -3.93% | -4.53% |
ALC | total equity-based compensation | -7.13% | -7.85% | -8.45% |
ALC | total impairment charges on property, plant & equipment, net | 0.0 | -0.10% | 0.0 |
ALC | total segment contribution | 100.00% | 100.00% | 100.00% |
ALC | transformation costs | -6.23% | -6.15% | -3.80% |
ALC | not allocated to segments::total depreciation of property, plant & equipment | -0.18% | -0.05% | 0.0 |
ALC | not allocated to segments::total equity-based compensation | -0.76% | -0.88% | -0.95% |
ALC | surgical::impairment charges | 0.0 | -3.10% | -9.96% |
ALC | surgical::impairment charges on intangible assets | 0.0 | -3.10% | 0.0 |
ALC | surgical::segment contribution | 0.0 | 69.01% | 66.22% |
ALC | surgical::total depreciation of property, plant & equipment | -6.45% | -6.77% | -7.21% |
ALC | surgical::total depreciation of right-of-use assets | -2.20% | -2.38% | -2.80% |
ALC | surgical::total equity-based compensation | -3.50% | -3.82% | -4.14% |
ALC | surgical::total impairment charges on property, plant & equipment, net | 0.0 | -0.10% | 0.0 |
ALC | surgical::total segment contribution | 65.17% | 69.01% | 66.22% |
ALC | vision care::impairment charges | 0.0 | -0.10% | -2.63% |
ALC | vision care::impairment charges on intangible assets | 0.0 | -0.10% | -2.63% |
ALC | vision care::segment contribution | 0.0 | 30.99% | 33.78% |
ALC | vision care::total depreciation of property, plant & equipment | -10.62% | -10.23% | -10.85% |
ALC | vision care::total depreciation of right-of-use assets | -1.88% | -1.55% | -1.73% |
ALC | vision care::total equity-based compensation | -2.87% | -3.15% | -3.36% |
ALC | vision care::total segment contribution | 34.83% | 30.99% | 33.78% |
Ticker | Entry | 2019 | 2018 |
---|---|---|---|
ALC | surgical::disclosure of operating segments::segment contribution, increase (decrease) | 100.00% | 100.00% |
ALC | vision care::disclosure of operating segments::segment contribution, increase (decrease) | 50.00% | 18.18% |
Ticker | Entry | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
---|---|---|---|---|---|---|---|
ALC | net sales | 99.24% | 99.10% | 99.28% | 0.0 | 98.98% | 98.06% |
ALC | net sales and other revenues | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% |
ALC | net sales to third parties | 0.0 | 99.10% | 99.28% | 99.17% | 98.98% | 98.06% |
ALC | other revenues | 0.0 | 0.90% | 0.72% | 0.83% | 1.02% | 1.94% |
ALC | total other revenues | 0.76% | 0.90% | 0.72% | 0.0 | 0.0 | 0.0 |
ALC | operating segments::net sales | 99.24% | 99.10% | 99.28% | 0.0 | 0.0 | 0.0 |
ALC | operating segments::total other revenues | 0.0 | 0.90% | 0.72% | 0.0 | 0.0 | 0.0 |
ALC | surgical | consumables::net sales | 28.87% | 28.76% | 28.67% | 0.0 | 28.57% | 30.69% |
ALC | surgical | consumables::net sales to third parties | 0.0 | 28.76% | 28.67% | 28.80% | 28.57% | 30.69% |
ALC | surgical | equipment & other::net sales | 0.0 | 0.0 | 0.0 | 0.0 | 9.25% | 8.79% |
ALC | surgical | equipment/other::net sales | 8.94% | 9.43% | 9.42% | 0.0 | 0.0 | 0.0 |
ALC | surgical | equipment/other::net sales to third parties | 0.0 | 9.43% | 9.42% | 9.56% | 9.25% | 8.79% |
ALC | surgical | implantables::net sales | 17.91% | 18.01% | 19.79% | 0.0 | 16.48% | 16.12% |
ALC | surgical | implantables::net sales to third parties | 0.0 | 18.01% | 19.79% | 18.36% | 16.48% | 16.12% |
ALC | surgical::net sales | 55.72% | 56.20% | 57.88% | 0.0 | 54.30% | 55.59% |
ALC | surgical::net sales to third parties | 0.0 | 56.20% | 57.88% | 56.72% | 54.30% | 55.59% |
ALC | surgical::total other revenues | 0.04% | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
ALC | vision care | contact lenses::net sales | 26.32% | 25.38% | 25.15% | 0.0 | 26.90% | 26.23% |
ALC | vision care | contact lenses::net sales to third parties | 0.0 | 25.38% | 25.15% | 25.80% | 26.90% | 26.23% |
ALC | vision care | ocular health::net sales | 17.20% | 17.51% | 16.26% | 0.0 | 17.78% | 16.24% |
ALC | vision care | ocular health::net sales to third parties | 0.0 | 17.51% | 16.26% | 16.64% | 17.78% | 16.24% |
ALC | vision care::net sales | 43.53% | 42.90% | 41.40% | 0.0 | 44.68% | 42.46% |
ALC | vision care::net sales to third parties | 0.0 | 42.90% | 41.40% | 42.44% | 44.68% | 42.46% |
ALC | vision care::total other revenues | 0.72% | 0.90% | 0.72% | 0.0 | 0.0 | 0.0 |
Ticker | Entry | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
---|---|---|---|---|---|---|---|---|
ALC | intangible assets and goodwill | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% |
ALC | acquired in-process research & development::intangible assets and goodwill | 9.03% | 8.16% | 7.63% | 6.35% | 7.99% | 7.09% | 2.30% |
ALC | alcon brand name::intangible assets and goodwill | 34.70% | 32.89% | 30.76% | 34.00% | 32.76% | 29.13% | 27.91% |
ALC | currently marketed products::intangible assets and goodwill | 20.31% | 22.27% | 24.56% | 15.20% | 13.66% | 15.62% | 17.30% |
ALC | goodwill::intangible assets and goodwill | 104.18% | 98.52% | 92.58% | 101.60% | 97.89% | 87.04% | 83.33% |
ALC | marketing know-how::intangible assets and goodwill | 30.53% | 31.58% | 31.98% | 38.08% | 39.31% | 37.28% | 37.96% |
ALC | not allocated to segments | alcon brand name::intangible assets and goodwill | 34.70% | 32.89% | 30.76% | 34.00% | 32.76% | 29.13% | 27.91% |
ALC | not allocated to segments::intangible assets and goodwill | 34.70% | 32.89% | 30.76% | 34.00% | 32.76% | 29.13% | 27.91% |
ALC | other (including software)::intangible assets and goodwill | 5.10% | 4.44% | 4.13% | 4.87% | 4.41% | 4.27% | 3.43% |
ALC | surgical | acquired in-process research & development::intangible assets and goodwill | 6.54% | 6.23% | 5.82% | 6.33% | 7.95% | 7.05% | 2.02% |
ALC | surgical | currently marketed products::intangible assets and goodwill | 6.77% | 5.89% | 6.02% | 2.61% | 2.72% | 3.66% | 4.10% |
ALC | surgical | goodwill::intangible assets and goodwill | 53.15% | 50.15% | 46.90% | 51.84% | 49.95% | 44.41% | 42.49% |
ALC | surgical | marketing know-how::intangible assets and goodwill | 30.53% | 31.58% | 31.98% | 38.08% | 39.31% | 0.0 | 0.0 |
ALC | surgical | other (including software)::intangible assets and goodwill | 3.16% | 2.66% | 2.48% | 2.86% | 2.61% | 1.80% | 1.50% |
ALC | surgical | technologies::intangible assets and goodwill | 0.33% | 0.66% | 0.94% | 1.49% | 1.87% | 0.0 | 0.0 |
ALC | surgical::intangible assets and goodwill | 47.33% | 47.02% | 47.24% | 51.39% | 54.45% | 56.40% | 56.68% |
ALC | technologies::intangible assets and goodwill | 0.33% | 0.66% | 0.94% | 1.49% | 1.87% | 6.62% | 11.10% |
ALC | vision care | acquired in-process research & development::intangible assets and goodwill | 2.48% | 1.93% | 1.81% | 0.02% | 0.04% | 0.04% | 0.28% |
ALC | vision care | currently marketed products::intangible assets and goodwill | 13.54% | 16.38% | 18.55% | 12.58% | 10.95% | 11.96% | 13.20% |
ALC | vision care | goodwill::intangible assets and goodwill | 51.03% | 48.37% | 45.68% | 49.75% | 47.94% | 42.63% | 40.84% |
ALC | vision care | other (including software)::intangible assets and goodwill | 1.94% | 1.78% | 1.65% | 2.01% | 1.80% | 2.47% | 1.93% |
ALC | vision care::intangible assets and goodwill | 17.97% | 20.09% | 22.00% | 14.61% | 12.80% | 14.48% | 15.41% |
Ticker | Entry | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
---|---|---|---|---|---|---|---|
ALC | net sales | 41.26% | 37.50% | 0.0 | 0.0 | 0.0 | 0.0 |
ALC | intangible assets and goodwill | 39.90% | 41.99% | 0.0 | 0.0 | 0.0 | 0.0 |
ALC | net sales to third parties | 41.26% | 37.50% | 37.80% | 31.04% | 32.61% | 31.83% |
ALC | total of selected non-current asset | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% |
ALC | total of selected non-current assets | 100.00% | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
ALC | china::net sales | 2.32% | 2.05% | 0.0 | 0.0 | 0.0 | 0.0 |
ALC | china::total of selected non-current assets | 0.04% | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
ALC | country of domicile | switzerland::net sales to third parties | 0.28% | 0.26% | 0.28% | 0.25% | 0.25% | 0.25% |
ALC | country of domicile | switzerland::percentage of entity's non-current asset | 0.0 | 0.18% | 0.0 | 0.0 | 0.0 | 0.0 |
ALC | country of domicile | switzerland::percentage of entity's non-current asset (as a percent) | 0.18% | 0.18% | 0.0 | 0.0 | 0.0 | 0.0 |
ALC | country of domicile | switzerland::total of selected non-current asset | 0.04% | 41.01% | 44.88% | 44.70% | 46.45% | 49.72% |
ALC | foreign countries | china::net sales to third parties | 2.32% | 2.05% | 2.23% | 1.76% | 1.67% | 1.52% |
ALC | foreign countries | china::percentage of entity's revenue | 0.0 | 0.02% | 0.0 | 0.0 | 0.0 | 0.0 |
ALC | foreign countries | china::percentage of entity's revenue (as a percent) | 0.03% | 0.02% | 0.0 | 0.0 | 0.0 | 0.0 |
ALC | foreign countries | china::total of selected non-current asset | 0.04% | 0.04% | 0.07% | 0.07% | 0.08% | 0.01% |
ALC | foreign countries | japan::net sales to third parties | 2.57% | 2.46% | 2.85% | 2.98% | 2.91% | 2.64% |
ALC | foreign countries | japan::percentage of entity's revenue | 0.0 | 0.03% | 0.0 | 0.0 | 0.0 | 0.0 |
ALC | foreign countries | japan::percentage of entity's revenue (as a percent) | 0.03% | 0.03% | 0.0 | 0.0 | 0.0 | 0.0 |
ALC | foreign countries | japan::total of selected non-current asset | 0.15% | 0.19% | 0.21% | 0.29% | 0.29% | 0.05% |
ALC | foreign countries | other::net sales to third parties | 17.11% | 15.84% | 15.65% | 12.39% | 14.26% | 14.32% |
ALC | foreign countries | other::percentage of entity's non-current asset | 0.0 | 0.03% | 0.0 | 0.0 | 0.0 | 0.0 |
ALC | foreign countries | other::percentage of entity's non-current asset (as a percent) | 0.04% | 0.03% | 0.0 | 0.0 | 0.0 | 0.0 |
ALC | foreign countries | other::percentage of entity's revenue | 0.0 | 0.18% | 0.0 | 0.0 | 0.0 | 0.0 |
ALC | foreign countries | other::percentage of entity's revenue (as a percent) | 0.18% | 0.18% | 0.0 | 0.0 | 0.0 | 0.0 |
ALC | foreign countries | other::total of selected non-current asset | 8.97% | 7.89% | 7.95% | 7.62% | 6.40% | 5.44% |
ALC | foreign countries | united states::net sales to third parties | 18.99% | 16.89% | 16.78% | 13.66% | 13.53% | 13.10% |
ALC | foreign countries | united states::percentage of entity's non-current asset | 0.0 | 0.22% | 0.0 | 0.0 | 0.0 | 0.0 |
ALC | foreign countries | united states::percentage of entity's non-current asset (as a percent) | 0.22% | 0.22% | 0.0 | 0.0 | 0.0 | 0.0 |
ALC | foreign countries | united states::percentage of entity's revenue | 0.0 | 0.20% | 0.0 | 0.0 | 0.0 | 0.0 |
ALC | foreign countries | united states::percentage of entity's revenue (as a percent) | 0.20% | 0.20% | 0.0 | 0.0 | 0.0 | 0.0 |
ALC | foreign countries | united states::total of selected non-current asset | 0.05% | 0.05% | 46.89% | 47.32% | 46.78% | 44.78% |
ALC | goodwill::intangible assets and goodwill | 39.31% | 38.68% | 0.0 | 0.0 | 0.0 | 0.0 |
ALC | international::net sales | 22.27% | 20.62% | 0.0 | 0.0 | 0.0 | 0.0 |
ALC | international::net sales to third parties | 22.27% | 20.62% | 21.01% | 17.39% | 19.08% | 18.73% |
ALC | international::total of selected non-current asset | 49.40% | 49.13% | 53.11% | 52.68% | 53.22% | 55.22% |
ALC | international::total of selected non-current assets | 49.40% | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
ALC | japan::net sales | 2.57% | 2.46% | 0.0 | 0.0 | 0.0 | 0.0 |
ALC | japan::total of selected non-current assets | 0.15% | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
ALC | other::net sales | 17.11% | 15.84% | 0.0 | 0.0 | 0.0 | 0.0 |
ALC | other::total of selected non-current assets | 8.97% | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
ALC | switzerland::net sales | 0.28% | 0.26% | 0.0 | 0.0 | 0.0 | 0.0 |
ALC | switzerland::total of selected non-current assets | 40.24% | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
ALC | united states::net sales | 18.99% | 16.89% | 0.0 | 0.0 | 0.0 | 0.0 |
ALC | united states::total of selected non-current assets | 50.60% | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Ticker | Entry | 2020 | 2019 | 2018 | 2017 |
---|---|---|---|---|---|
ALC | interest expense | -1.81% | -1.51% | -0.34% | -0.40% |
ALC | (loss) before tax | -9.29% | -4.42% | -4.19% | -1.87% |
ALC | amortization of intangible assets | -15.78% | -14.44% | -14.25% | -15.21% |
ALC | contingent consideration asset (liability), fair value adjustment | 0.92% | 1.00% | 0.87% | 0.0 |
ALC | depreciation of property, plant & equipment | -4.29% | -3.56% | -3.34% | -3.17% |
ALC | depreciation of right-of-use assets | -1.16% | -0.88% | 0.0 | 0.0 |
ALC | equity-based compensation | -1.65% | -1.52% | -1.30% | -1.05% |
ALC | general & administration (corporate) | -3.40% | -2.88% | -2.88% | -2.97% |
ALC | impairment charges on intangible assets | -2.44% | 0.0 | -5.28% | -0.84% |
ALC | impairment charges on property, plant & equipment, net | -0.09% | -0.11% | -0.03% | 0.0 |
ALC | net sales and other revenues | 100.00% | 100.00% | 100.00% | 100.00% |
ALC | net sales to third parties | 98.98% | 98.06% | 99.94% | 99.90% |
ALC | operating (loss) | -7.05% | -2.49% | -3.47% | -1.13% |
ALC | other | -0.69% | -1.81% | -0.73% | -1.49% |
ALC | other financial income & expense | -0.42% | -0.43% | -0.39% | -0.34% |
ALC | other revenues | 1.02% | 1.94% | 0.0 | 0.04% |
ALC | past service costs for post-employment benefit plan amendments | 2.25% | -0.03% | -0.01% | 0.0 |
ALC | payables contingent consideration | -0.92% | -1.00% | -0.87% | 0.0 |
ALC | sales to former parent | 0.0 | 0.0 | 0.06% | 0.06% |
ALC | segment contribution | 15.97% | 20.47% | 20.22% | 19.38% |
ALC | separation costs | -3.18% | -3.16% | 0.0 | 0.0 |
ALC | spin readiness costs | 0.0 | -0.96% | -0.45% | 0.0 |
ALC | transformation costs | -0.72% | -0.69% | 0.0 | 0.0 |
ALC | surgical::depreciation of property, plant & equipment | -1.79% | -1.49% | -1.59% | -1.56% |
ALC | surgical::depreciation of right-of-use assets | -0.69% | -0.56% | 0.0 | 0.0 |
ALC | surgical::equity-based compensation | -0.80% | -0.73% | -0.63% | -0.50% |
ALC | surgical::impairment charges on intangible assets | -0.97% | 0.0 | -5.28% | 0.0 |
ALC | surgical::impairment charges on property, plant & equipment, net | -0.09% | -0.04% | -0.01% | 0.0 |
ALC | surgical::net sales and other revenues | 54.30% | 55.59% | 55.93% | 55.01% |
ALC | surgical::net sales to third parties | 54.30% | 55.59% | 55.91% | 54.96% |
ALC | surgical::sales to former parent | 0.0 | 0.0 | 0.03% | 0.04% |
ALC | surgical::segment contribution | 9.83% | 12.75% | 11.83% | 10.17% |
ALC | unallocated amounts::equity-based compensation | -0.19% | -0.20% | -0.17% | -0.15% |
ALC | vision care::depreciation of property, plant & equipment | -2.50% | -2.06% | -1.75% | -1.60% |
ALC | vision care::depreciation of right-of-use assets | -0.47% | -0.32% | 0.0 | 0.0 |
ALC | vision care::equity-based compensation | -0.66% | -0.59% | -0.50% | -0.40% |
ALC | vision care::impairment charges on intangible assets | -1.48% | 0.0 | 0.0 | 0.0 |
ALC | vision care::impairment charges on property, plant & equipment, net | 0.0 | -0.07% | -0.01% | 0.0 |
ALC | vision care::net sales and other revenues | 45.70% | 44.41% | 44.07% | 44.99% |
ALC | vision care::net sales to third parties | 44.68% | 42.46% | 44.04% | 44.94% |
ALC | vision care::sales to former parent | 0.0 | 0.0 | 0.03% | 0.01% |
ALC | vision care::segment contribution | 6.13% | 7.73% | 8.39% | 9.20% |